Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
16.11
-0.34 (-2.07%)
At close: Feb 11, 2026, 4:00 PM EST
16.35
+0.24 (1.49%)
After-hours: Feb 11, 2026, 5:03 PM EST
Nurix Therapeutics Market Cap
Nurix Therapeutics has a market cap or net worth of $1.66 billion as of February 11, 2026. Its market cap has increased by 18.07% in one year.
Market Cap
1.66B
Enterprise Value
1.12B
1-Year Change
18.07%
Ranking
Category
Stock Price
$16.11
Market Cap Chart
Since July 24, 2020, Nurix Therapeutics's market cap has increased from $704.09M to $1.66B, an increase of 135.31%. That is a compound annual growth rate of 16.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 1.69B | -12.02% |
| Dec 31, 2025 | 1.92B | 44.09% |
| Dec 31, 2024 | 1.33B | 166.61% |
| Dec 29, 2023 | 500.56M | -3.31% |
| Dec 30, 2022 | 517.68M | -59.92% |
| Dec 31, 2021 | 1.29B | 1.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tango Therapeutics | 1.70B |
| Innoviva | 1.68B |
| Immunocore Holdings | 1.67B |
| Enliven Therapeutics | 1.66B |
| Corvus Pharmaceuticals | 1.65B |
| Oculis Holding AG | 1.65B |
| MBX Biosciences | 1.65B |
| Veradermics | 1.64B |